Kymera
clinical | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
44 of 63
Related slides by other companies
Alkermes
Investor Conference
January 2024
phase designed to capture standard and exploratory measures | Alkermes
Oculis
Results
May 2023
stage recap trial objectives met results validated loading and maintenance regimen to optimize efficacy potential in with robust statistical significance met all functional and clinical benefit in a robust statistically superior manner in month trial no unexpected safety findings observed next step commence stage of program to support filing of for treatment | Oculis
argenx SE
Results
July 2023
positive topline results primary stage a response rate safety and tolerability adhere | argenx SE
Adagio Therapeutics
Investor Conference
January 2022
two global clinical trials evaluating for prevention and treatment of covid | Adagio Therapeutics
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights